Omada Health
OMDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $68 | $61 | $55 | $48 |
| % Growth | 10.9% | 11.7% | 14.6% | – |
| Cost of Goods Sold | $23 | $21 | $23 | $16 |
| Gross Profit | $45 | $40 | $32 | $32 |
| % Margin | 66.3% | 65.5% | 58% | 66.6% |
| R&D Expenses | $10 | $10 | $9 | $9 |
| G&A Expenses | $14 | $12 | $11 | $0 |
| SG&A Expenses | $37 | $35 | $31 | $30 |
| Sales & Mktg Exp. | $23 | $22 | $20 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $48 | $45 | $40 | $39 |
| Operating Income | -$3 | -$4 | -$8 | -$7 |
| % Margin | -3.7% | -7.1% | -15.3% | -14.8% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$3 | -$5 | -$9 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$5 | -$9 | -$8 |
| % Margin | -4.7% | -8.7% | -17.2% | -17.2% |
| EPS | -0.055 | -0.093 | -0.17 | -0.15 |
| % Growth | 40.5% | 45.5% | -13.3% | – |
| EPS Diluted | -0.06 | -0.093 | -0.17 | -0.15 |
| Weighted Avg Shares Out | 53 | 57 | 56 | 56 |
| Weighted Avg Shares Out Dil | 58 | 57 | 56 | 56 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $0 |
| Interest Expense | $0 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$2 | -$3 | -$7 | -$6 |
| % Margin | -2.7% | -4.7% | -12.8% | -12.2% |